Hereditary coagulation factor XI deficiency : a rare or neglected disease? Results from a retrospective, single-centre cohort in northern Italy
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved..
To examine real-life clinical data regarding hereditary factor XI (FXI) deficiency from a secondary care centre. Retrospective review of clinical records for every FXI:C 0.7 IU/ml or less reported from 2012 to 2020. Seventy-nine patients were included. Six (7.6%) had a severe deficiency (FXI:C <0.2 IU/ml). Only 55 (69.6%) patients were referred to the Haemostasis Centre. Among them, six (15%) were subsequently not identified at increased haemorrhagic risk before a surgical/obstetrical procedure. Thirty-three (41.8%) experienced at least one bleeding event, minor (25 patients) and/or major (16 patients). Minor bleedings were predominantly spontaneous and more frequent in women, major events were mainly provoked. No correlation was found between FXI:C and risk of bleeding ( P = 0.9153). Lower FXI:C, but not a positive bleeding history, was related with higher likelihood of being referred to the Haemostasis Centre ( P = 0.0333). Hereditary FXI deficiency prevalence is likely underestimated, real-life clinical practices outside reference centres could be suboptimal.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
---|---|
Enthalten in: |
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis - 35(2024), 1 vom: 01. Jan., Seite 32-36 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Canovi, Simone [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 11.01.2024 Date Revised 01.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1097/MBC.0000000000001270 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM36542594X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM36542594X | ||
003 | DE-627 | ||
005 | 20240201232033.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1097/MBC.0000000000001270 |2 doi | |
028 | 5 | 2 | |a pubmed24n1277.xml |
035 | |a (DE-627)NLM36542594X | ||
035 | |a (NLM)38051652 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Canovi, Simone |e verfasserin |4 aut | |
245 | 1 | 0 | |a Hereditary coagulation factor XI deficiency |b a rare or neglected disease? Results from a retrospective, single-centre cohort in northern Italy |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.01.2024 | ||
500 | |a Date Revised 01.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved. | ||
520 | |a To examine real-life clinical data regarding hereditary factor XI (FXI) deficiency from a secondary care centre. Retrospective review of clinical records for every FXI:C 0.7 IU/ml or less reported from 2012 to 2020. Seventy-nine patients were included. Six (7.6%) had a severe deficiency (FXI:C <0.2 IU/ml). Only 55 (69.6%) patients were referred to the Haemostasis Centre. Among them, six (15%) were subsequently not identified at increased haemorrhagic risk before a surgical/obstetrical procedure. Thirty-three (41.8%) experienced at least one bleeding event, minor (25 patients) and/or major (16 patients). Minor bleedings were predominantly spontaneous and more frequent in women, major events were mainly provoked. No correlation was found between FXI:C and risk of bleeding ( P = 0.9153). Lower FXI:C, but not a positive bleeding history, was related with higher likelihood of being referred to the Haemostasis Centre ( P = 0.0333). Hereditary FXI deficiency prevalence is likely underestimated, real-life clinical practices outside reference centres could be suboptimal | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Factor XI |2 NLM | |
650 | 7 | |a 9013-55-2 |2 NLM | |
700 | 1 | |a Leone, Maria Cristina |e verfasserin |4 aut | |
700 | 1 | |a Depietri, Luca |e verfasserin |4 aut | |
700 | 1 | |a Veropalumbo, Maria Rosaria |e verfasserin |4 aut | |
700 | 1 | |a Pilia, Annalisa |e verfasserin |4 aut | |
700 | 1 | |a Granito, Maria |e verfasserin |4 aut | |
700 | 1 | |a Bonanno, Antonio |e verfasserin |4 aut | |
700 | 1 | |a Casali, Annamaria |e verfasserin |4 aut | |
700 | 1 | |a Colla, Rossana |e verfasserin |4 aut | |
700 | 1 | |a Ghirarduzzi, Angelo |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis |d 1992 |g 35(2024), 1 vom: 01. Jan., Seite 32-36 |w (DE-627)NLM012606456 |x 1473-5733 |7 nnns |
773 | 1 | 8 | |g volume:35 |g year:2024 |g number:1 |g day:01 |g month:01 |g pages:32-36 |
856 | 4 | 0 | |u http://dx.doi.org/10.1097/MBC.0000000000001270 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 35 |j 2024 |e 1 |b 01 |c 01 |h 32-36 |